The PI3-kinase/AKT pathway is more and more regarded as an interesting therapeutic target for the radiosensitization of glioblastoma, but the mechanisms of radiosensitization resulting from the inhibition of the PI3K/AKT pathway remain still unclear. The gene discussed is AKT1; the disease is glioblastoma.